Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma
- PMID: 23489940
- DOI: 10.1016/j.surg.2012.12.008
Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma
Abstract
Background: This study was conducted to identify the relevant cutoff value and to evaluate the usefulness of postoperative-stimulated serum thyroglobulin (Tg) at the time of (131)I ablation for the prediction of disease status in patients with differentiated thyroid carcinoma (DTC) who received high-dose (131)I ablation therapy after total thyroidectomy.
Methods: We analyzed 218 consecutively enrolled patients who were diagnosed with DTC and underwent total thyroidectomy. All patients underwent (131)I ablation at doses of 100-200 mCi, and stimulated serum Tg was measured at the time of (131)I ablation therapy. To assess disease-free status after (131)I ablation therapy, stimulated serum Tg levels, diagnostic whole-body scan (DxWBS) and neck ultrasonography (US) were performed 6-12 months after (131)I ablation.
Results: The relevant cutoff value of postoperative stimulated Tg for the prediction of disease-free status was 2 ng/mL. A total of 138 patients (63.3%) showed values of <2 ng/mL. Postoperative-stimulated Tg < 2 ng/mL had a negative predictive value of 94.9%, which increased to 97.7% when low Tg was combined with negative neck US findings.
Conclusion: Postoperative-stimulated Tg at the time of (131)I remnant ablation is a useful biochemical marker for the prediction of disease status in patients with DTC. When high-dose (131)I remnant ablation is performed after total thyroidectomy, the stimulated Tg measurement and DxWBS that are usually performed 6-12 months after (131)I ablation therapy may be skipped, at least in low- and intermediate-risk patients with postoperative stimulated Tg of < 2 ng/mL and negative neck US findings.
Copyright © 2013 Mosby, Inc. All rights reserved.
Similar articles
-
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6. Thyroid. 2012. PMID: 22224815
-
Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.Asian Pac J Cancer Prev. 2014;15(6):2523-7. doi: 10.7314/apjcp.2014.15.6.2523. Asian Pac J Cancer Prev. 2014. PMID: 24761858
-
Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.Clin Endocrinol (Oxf). 2008 Oct;69(4):659-63. doi: 10.1111/j.1365-2265.2008.03244.x. Epub 2008 Mar 18. Clin Endocrinol (Oxf). 2008. PMID: 18363882
-
Follow-up of differentiated thyroid carcinoma.Minerva Endocrinol. 2004 Dec;29(4):161-74. Minerva Endocrinol. 2004. PMID: 15765026 Review. English, Italian.
-
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.Endocr Relat Cancer. 2011 Mar 3;18(2):R29-40. doi: 10.1677/ERC-10-0292. Print 2011 Apr. Endocr Relat Cancer. 2011. PMID: 21183629 Review.
Cited by
-
Secondary thyroid carcinoma in survivors of childhood cancer: A need to revise current screening recommendations.Clin Endocrinol (Oxf). 2022 Jul;97(1):137-139. doi: 10.1111/cen.14746. Epub 2022 Apr 30. Clin Endocrinol (Oxf). 2022. PMID: 35460104 Free PMC article. No abstract available.
-
Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine.Endocrine. 2022 Jun;76(3):642-647. doi: 10.1007/s12020-022-03021-y. Epub 2022 Mar 2. Endocrine. 2022. PMID: 35237910
-
Predictive Factors for Skip Lymph Node Metastasis and Their Implication on Recurrence in Papillary Thyroid Carcinoma.Biomedicines. 2022 Jan 16;10(1):179. doi: 10.3390/biomedicines10010179. Biomedicines. 2022. PMID: 35052858 Free PMC article.
-
Can shear wave elastography determine remnant thyroid tissue in the early postoperative period in patients with differentiated thyroid carcinoma?J Ultrasound. 2022 Jun;25(2):273-280. doi: 10.1007/s40477-021-00576-w. Epub 2021 Apr 5. J Ultrasound. 2022. PMID: 33818752 Free PMC article.
-
2020 Imaging Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer: Korean Society of Thyroid Radiology.Korean J Radiol. 2021 May;22(5):840-860. doi: 10.3348/kjr.2020.0578. Epub 2021 Feb 9. Korean J Radiol. 2021. PMID: 33660459 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous